Milestone Payment. First dosing of any Product to a subject in a Phase III Trial Fifteen million dollars ($15,000,000) [*] [*] million dollars ($[*]) [*] [*] million dollars ($[*]) [*] [*] million dollars ($[*]) [*] [*] million dollars ($[*]) [*] [*] million dollars ($[*]) [*] [*] million [*] thousand dollars ($[*]) [*] Confidential treatment requested; certain information omitted and filed separately with the SEC.
Appears in 3 contracts
Sources: Confidentiality Agreement (Furiex Pharmaceuticals, Inc.), Confidentiality Agreement (Furiex Pharmaceuticals, Inc.), Confidentiality Agreement (Pharmaceutical Product Development Inc)
Milestone Payment. First dosing Dosing of any Product to a the twentieth (20th) subject in a Phase III Trial Fifteen million dollars ($15,000,000) [*] [*] million dollars ($[*]) [*] [*] million dollars ($[*]) [*] [*] million dollars ($[*]) [*] [*] million dollars ($[*]) [*] [*] million dollars ($[*]) [*] [*] million [*] hundred thousand dollars ($[*]) [*] Confidential treatment requested; certain information omitted and filed separately with the SEC.)
Appears in 3 contracts
Sources: Confidentiality Agreement (Furiex Pharmaceuticals, Inc.), Confidentiality Agreement (Furiex Pharmaceuticals, Inc.), Amendment No. 1 to the Agreement (Pharmaceutical Product Development Inc)